Viagra. Third best-selling drug in Russia in 2010
Photo: Shalom Bar-Tal
Pfizer starts Viagra case against Teva
American drugmaker files patent infringement suit to prevent Israel-based rival from selling generic version of its erectile dysfunction drug in Russia
Pfizer said this week it had filed a patent infringement suit in a Moscow court against Teva Pharmaceutical to prevent the Israel-based
rival from selling a generic version of its erectile dysfunction drug Viagra in Russia.
Pfizer has already won a patent infringement case against Teva in a US court, preventing Teva from launching its generic drug until October 2019.
Viagra was the third best-selling drug in Russia in 2010 when the US drugmaker sold $117 million of the medicine, according to industry research group Pharmexpert, out of nearly $2 billion in worldwide sales.
In the first eight months of this year, Russian sales of Viagra were up 14% in money terms to stand at $86.7 million, although sales were down 6.5% in volume terms, Pharmexpert said.
- Follow Ynetnews on Facebook
